LAVAL, QC Stefan Clulow appointed as Chair of the Board Kenneth Galbraith appointed as Chief Executive Officer LAVAL, QC, April 23, 2019 /CNW Telbec/ – Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) (“Prometic” or the “Corporation”) is pleased to announce today’s closing of the recapitalization and equity offering previously announced on April 15, 2019. Prometic received C$75 million (approximately US$56 million) in gross proceeds from the equity […]
CAMBRIDGE, Mass.–ZAGENO, the leading enterprise marketplace for lab supplies, today announced it raised a $20 million Series B round led by General Catalyst, with follow-on investment from Grazia Equity and Capnamic Ventures. ZAGENO curated more than 8 million research materials and products from premium manufacturing brands on its online platform to serve this $130 billion […]
LONGMONT, Colo. — KromaTiD, Inc. announced today that after successfully meeting the Phase 1 grant milestones, the company has been awarded Phase 2 funding from a Fast Track Small Business Innovation Research (SBIR) grant from the National Human Genome Research Institute. The SBIR program enables scientific excellence and technological innovation by incentivizing small businesses to […]
Phasefocus, the Sheffield-based company supplying tools to help researchers develop cures for cancer and stem cell therapies, has secured additional investment as it prepares to launch the newest version of its flagship live cell imaging and analysis system, Livecyte™. Livecyte enables research biologists to automatically quantify and compare dynamic live cell behaviour in an easy-to-use […]
Prairie Capital VI, LP partnered with CEO Drew Hall and other management to recapitalize Analytical Sensors & Instruments, Inc. (“ASI” or the “Company”). ASI is a vertically-integrated engineer and manufacturer of electrodes, analytical sensors and chemical solutions used in a variety of water testing applications for industrial water treatment, laboratory, environmental, pool and aquaculture end […]
Cambridge start-up Sano Genetics has raised £500,000 seed funding for its innovative research platform that is set to transform drug discovery and accelerate the growth of personalised medicine. The company will enable large-scale genetic and medical research without sacrificing data privacy — by putting the patient in the driving seat. The Sano platform is powering research into many common […]
Advancement of autoimmune program demonstrates continued success of Schrödinger computational platform for drug discovery NEW YORK – Schrödinger today announced receipt of a milestone payment from Sanofi (EURONEXT: SAN, NASDAQ: SNY) to mark the advancement into the clinic of an autoimmune therapy discovered as part of a multi-year, multi-target collaboration between the two companies. Under the […]
Continued support of existing investors will fund commercialization efforts, product launch later this year Boulder, CO – Inscripta, a leading gene-editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new funding adds to the $85.5 million financing Inscripta announced in […]
TTP plc invests £1.7m ($2.2m), to fast-track development of first commercial product, Highway 1™, bench-top cell-sorting instrument Highway 1 addresses a major unmet need for improved cell-sorting technology, with applications including development of cell therapies, liquid biopsy diagnostics, and high-throughput drug discovery Advanced cell-sorting technology is based on Vortex-Actuated Cell Sorting technology, developed to support […]
– Applied DNA to Receive Staged Payments Totaling $5M Over the Next Four-Months – – Agreement Calls for Annual Payment Minima that Scale from $7 Million in Year 3 to $20 Million in Year 15 – – Applied DNA Technology to Power ETCH BioTrace System to Verify Legal Cannabis and Hemp Markets Globally – STONY […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
